U.S. Markets open in 9 hrs, 17 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 02/22/2010 * | 18:00 | Q4 2009 Savient Pharmaceuticals, Inc. Earnings Release |  |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/05/2009 | Q3 2009 Savient Pharmaceuticals, Inc. Earnings Conference Call | — | Download($) |
| 11/04/2009 | Q3 2009 Savient Pharmaceuticals, Inc. Earnings Release | — | — |
| 11/03/2009 | Savient Pharmaceuticals, Inc. at Oppenheimer & Co. Healthcare Conference | — | — |
| 10/06/2009 | Savient Pharmaceuticals, Inc. at JMP Securities Healthcare Focus Conference | — | Download($) |
| 09/16/2009 | Savient Pharmaceuticals, Inc. to Discuss the Results of the Type A Meeting with the FDA - Conference Call | — | Download($) |
| 08/10/2009 | Q2 2009 Savient Pharmaceuticals, Inc. Earnings Release | — | — |
| 08/03/2009 | Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM) - Conference Call | — | Download($) |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts